| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.024 | 0.9 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |